Selenazolyl-hydrazones as Novel Selective MAO Inhibitors With Antiproliferative and Antioxidant Activities: Experimental and In-silico Studies

The novel approach in the treatment of complex multifactorial diseases, such as neurodegenerative disorders and cancer, requires a development of efficient multi-targeting oriented drugs. Since oxidative stress significantly contributes to the pathogenesis of cancer and neurodegenerative disorders,...

Descripción completa

Detalles Bibliográficos
Autores principales: Elshaflu, Hana, Todorović, Tamara R., Nikolić, Milan, Lolić, Aleksandar, Višnjevac, Aleksandar, Hagenow, Stefanie, Padrón, José M., García-Sosa, Alfonso T., Djordjević, Ivana S., Grubišić, Sonja, Stark, Holger, Filipović, Nenad R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037691/
https://www.ncbi.nlm.nih.gov/pubmed/30018949
http://dx.doi.org/10.3389/fchem.2018.00247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037691/
https://www.ncbi.nlm.nih.gov/pubmed/30018949
http://dx.doi.org/10.3389/fchem.2018.00247

Ejemplares similares